- Home
- BIO vs CHDN Comparison
BIO vs CHDN Comparison
Compare BIO & CHDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIO | CHDN |
|---|---|---|
| Founded | 1952 | 1928 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Services-Misc. Amusement & Recreation |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.9B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | BIO | CHDN |
|---|---|---|
| Price | $254.19 | $98.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $339.75 | $138.44 |
| AVG Volume (30 Days) | 241.5K | ★ 903.1K |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.49 |
| Revenue | N/A | ★ $1,809,800,000.00 |
| Revenue This Year | $2.74 | $5.75 |
| Revenue Next Year | $3.20 | $3.52 |
| P/E Ratio | ★ $9.72 | $18.47 |
| Revenue Growth | N/A | ★ 13.31 |
| 52 Week Low | $211.43 | $81.66 |
| 52 Week High | $343.12 | $118.46 |
Technical Indicators
Market Signals| Indicator | BIO | CHDN |
|---|---|---|
| Relative Strength Index (RSI) | 33.87 | 59.76 |
| Support Level | $246.01 | $85.57 |
| Resistance Level | $289.61 | $105.78 |
| Average True Range (ATR) | 10.43 | 3.50 |
| MACD | -3.76 | 0.81 |
| Stochastic Oscillator | 17.46 | 70.82 |
Price Performance
Historical ComparisonAbout BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.